CHE  Chemed Corp.

Exchange

NYSE

Sector

Health Care

Industry

Medical/Nursing Services

Market Cap.

1.766B

Vuru Grade

60.61/100

Current Price

$102.44
-0.35 (-0.34%)

Growth Price

$88.14
Overvalued by 13.96%

Stability Price

$100.68
Fairly valued

Company Metrics

  • 21.85 P/E
  • 1.26 P/S
  • 3.99 P/B
  • 4.705 EPS
  • 20.03% Cash ROIC
  • 0.23 Cash Ratio
  • 0.8 / 0.78% Dividend
  • 222,211.00 Avg. Vol.
  • 17.24M Shares
  • 1.766B Market Cap.

Company Description

Chemed Corporation, through its subsidiaries, provides hospice care, and repair and cleaning services in the United States. The company operates in two segments, Vitas and Roto-Rooter. The Vitas segment offers hospice services to terminally ill patients. This segment provides hospice services in the areas of routine home care, general inpatient care, continuous care, and Medicare cap. It also offe...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Chemed Corporation Announces a Five-Year $450 Million Amended and ...
MarketWatch - Jul 1, 2014
CINCINNATI, Jul 01, 2014 (BUSINESS WIRE) -- Chemed Corporation ("Chemed") (NYSE:CHE) announced that it has entered into an Amended and Restated Credit Agreement for its Credit Facility (“Credit Agreement”).
Insider Stock Sale at Chemed Corporation (CHE): Kevin Mcnamara Unloads ...
Tech Insider - Jul 28, 2014
Chemed Corporation (NYSE:CHE)' President and Chief Executive Officer, Kevin Mcnamara, sold 10,000 shares of Capital Stock on Friday.
Chemed Price Target Raised to $96.00 at RBC Capital (CHE) - WKRB News
Chemed Price Target Increased to $96.00 by Analysts at RBC Capital (CHE) - Watch List News (press release)
Chemed Corporation: Chemed To Report Second-Quarter 2014 Earnings July ...
The Wall Street Transcript - Jul 7, 2014
CINCINNATI--(BUSINESS WIRE)--Jul. 7, 2014-- Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2014, on Wednesday, July 23, 2014, following the close of trading on the New York ...
Chemed To Report Second-Quarter 2014 Earnings July 23rd, Related ... - Wall Street Journal
Chemed's (CHE) CEO Kevin McNamara on Q2 2014 Results - Earnings Call ...
Seeking Alpha (registration) - Jul 24, 2014
Good day, ladies and gentlemen, and welcome to the Second Quarter 2014 Chemed Corporation Earnings Conference Call. My name is Derrick and I'll be your operator for today.
Chemed (CHE) Releases Quarterly Earnings Results, Beats Expectations By ... - WKRB News
Chemed Co. (CHE) Issues FY14 Earnings Guidance - Ticker Report
Chemed VP Sells $911340 in Stock (CHE)
Watch List News (press release) - 22 hours ago
Chemed logo Chemed (NYSE:CHE) VP Arthur V. Tucker, Jr. sold 9,000 shares of the company's stock in a transaction that occurred on Friday, July 25th.
Chemed Reports Second-Quarter 2014 Results
Wall Street Journal - Jul 23, 2014
Chemed Corporation operates in the healthcare field through its VITAS Healthcare Corporation subsidiary. VITAS provides daily hospice services to over 14,000 patients with severe, life-limiting illnesses.
Chemed CEO Unloads $1010000 in Stock (CHE)
WKRB News - Jul 25, 2014
The company's revenue for the quarter was up .8% on a year-over-year basis. Analysts expect that Chemed will post $5.94 EPS for the current fiscal year.
Chemed CEO Sells $1010000 in Stock (CHE)
Watch List News (press release) - Jul 27, 2014
Chemed logo Chemed (NYSE:CHE) CEO Kevin J. Mcnamara sold 10,000 shares of the company's stock on the open market in a transaction dated Friday, July 25th.
Chemed VP Arthur V. Tucker, Jr. Sells 9000 Shares (CHE)
Intercooler - Jul 28, 2014
Shares of Chemed (NYSE:CHE) traded up 0.67% during mid-day trading on Monday, hitting $102.31. 278,468 shares of the company's stock traded hands. Chemed has a one year low of $64.16 and a one year high of $102.77. The stock has a 50-day ...
Chemed (CHE) Set to Announce Quarterly Earnings on Wednesday
Intercooler - Jul 22, 2014
Chemed logo Chemed (NYSE:CHE) will be issuing its Q214 quarterly earnings data on Wednesday, July 23rd. Analysts expect the company to announce earnings of $1.47 per share and revenue of $363.73 million for the quarter. Chemed has set its FY14 ...